13 Recruiting Trials

Clinical Trials
for Kidney Disease in Utah

13 clinical trials for Kidney Disease are currently recruiting participants at study sites in Utah. Study-related care is provided at no cost.

13
Recruiting trials
8
Study sites
3
Cities
9
Industry-sponsored
1
Phase 2
9
Phase 3

Kidney Disease clinical trials in Utah: what to expect

Kidney disease trials are mostly for chronic kidney disease that is slowly getting worse, including kidney disease caused by diabetes. They test medicines meant to slow the decline in kidney function and protect the heart, usually on top of the standard blood pressure and diabetes treatments. Specific kidney diseases such as IgA nephropathy, FSGS and polycystic kidney disease now have many trials of their own, and separate studies enroll people on dialysis or living with a transplant.

In Utah, recruiting kidney disease studies are concentrated in Salt Lake City, South Salt Lake and Ogden. 9 of the 13 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who kidney disease trials usually look for

Trials describe kidney disease by two numbers: the filtration rate (eGFR) from a blood test and the amount of protein in the urine. Most enroll an eGFR between about 20 and 75 and a urine protein level above a cut-off, both measured at screening. Nearly all ask that you have taken a stable dose of a blood-pressure medicine of the ACE inhibitor or ARB type for three months, and many allow or require an SGLT2 inhibitor. IgA nephropathy and FSGS trials need a past kidney biopsy. Common exclusions are a transplant, dialysis and uncontrolled blood pressure.

What taking part involves

Screening includes blood and urine tests, sometimes a 24-hour urine collection, and a review of your records. Trials then run one to three years with visits every four to twelve weeks for labs and blood pressure, taking a study pill or injection added to your usual medicines; placebo arms are common and an extension often follows. Your nephrologist keeps managing your care. Study medicine and tests are free and visits are usually paid.

Questions worth asking the study team

Which stage the trial enrolls and whether you fit it; whether any of your medicines change; how often labs are needed; the chance of placebo; and whether you will be told your own kidney results during the study.

Showing 13 of 13 recruiting Kidney Disease trials in Utah

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
PHASE3 Phoenix, Arizona +4 sites NCT05457283
This trial is looking for children and young adults aged 1 to 18 who have chronic kidney disease and proteinuria. Participants will take a treatment called finerenone alongside their current heart medicine for about 18 months.
Recruiting
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
PHASE3 Birmingham, Alabama +4 sites NCT07107945
This trial is looking for children aged 2 to 17 who have chronic kidney disease. Participants will take a daily tablet for 6 months followed by 1 year of another medication, with regular check-ups to monitor their health.
Recruiting
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
PHASE3 Huntsville, Alabama +4 sites NCT07753993
This trial is looking for adults with chronic kidney disease to see how well elecoglipron works compared to a placebo. Participants must be on certain medications for their condition before joining the study.
Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
PHASE3 Fairhope, Alabama +4 sites NCT06742723
This trial is looking for adults with chronic kidney disease and high blood pressure. If you join, you will take medications to see how they affect your kidney health and heart-related risks.
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
PHASE3 Birmingham, Alabama +4 sites NCT06963827
This trial is looking for adults with a kidney condition called IgA nephropathy. Participants will receive either mezagitamab or a placebo for 22 weeks and then be monitored for about 1.5 years.
Recruiting
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
N/A San Diego, California +4 sites NCT07006831
This trial is looking for kidney transplant patients to provide blood samples and information. The goal is to help develop a test that checks how well the transplanted kidney is functioning.
Recruiting
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
PHASE3 Long Beach, California +4 sites NCT05931276
This trial is looking for patients on hemodialysis who take certain beta blockers. Participants will receive either metoprolol or carvedilol to see how these medications affect heart health.
Recruiting
Sit Less, Interact and Move More (SLIMM) 2 Study
PHASE2 Salt Lake City, Utah +1 sites NCT05173714
This trial is looking for people with chronic kidney disease and obesity. Participants will undergo guided exercise and may take a medication to help reduce sitting time and improve health.
Recruiting
A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
PHASE3 Los Angeles, California +4 sites NCT03633708
This trial is looking for children under 18 with hyperparathyroidism and chronic kidney disease who are on hemodialysis. Participants will be monitored and treated with etelcalcetide during the study.
Recruiting
A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
PHASE3 Washington D.C., District of Columbia +4 sites NCT04782258
This trial is looking for infants and children aged 28 days to under 18 years who have a diagnosis of Autosomal Recessive Polycystic Kidney Disease (ARPKD). Participants will take a medication called tolvaptan to evaluate its safety and how it works for their condition.
Recruiting
Randomized Trial of SGLT2i in Heart Transplant Recipients
PHASE4 Salt Lake City, Utah +4 sites NCT06625073
This trial is looking for heart transplant recipients who are at least 3 months post-surgery. Participants will take either empagliflozin or a placebo daily for 12 months to see how it affects their kidney function and overall health.
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
PHASE3 Sun City, Arizona +4 sites NCT07662135
This trial is looking for adults with type 2 diabetes and kidney problems. Participants will take either elecoglipron or a placebo while continuing their diabetes medications.
Recruiting
ARPKD Database Study
N/A Washington D.C., District of Columbia +4 sites NCT01401998
This trial is looking for people with certain rare liver and kidney diseases. Participants will provide clinical information and may also share DNA or tissue samples to help improve understanding and treatment of these conditions.
Recruiting

Where the Kidney Disease studies are in Utah

  • University of Utah, Salt Lake City3 trials
  • Primary Children's Hospital, Salt Lake City2 trials
  • Research Site, South Salt Lake2 trials
  • VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City2 trials
  • Eccles Primary Children's Outpatient Services - Nephrology, Salt Lake City1 trial
  • Primary Childrens Hospital Outpatient Services, Salt Lake City1 trial

Counts are recruiting studies listing at least one site in Utah, from ClinicalTrials.gov, refreshed every two days.

Kidney Disease clinical trials in Utah: common questions

How many Kidney Disease clinical trials are recruiting in Utah?
TrialFinder currently lists 13 recruiting Kidney Disease clinical trials with study sites in Utah. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Kidney Disease clinical trials located in Utah?
Study sites for the Kidney Disease trials listed on this page include Salt Lake City. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Kidney Disease clinical trial in Utah?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Kidney Disease trials in Utah also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Kidney Disease clinical trial in Utah?
Each study sets its own criteria based on age, Kidney Disease diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
What stage of kidney disease do trials look for?
Trials state an eGFR range and a urine protein threshold rather than a stage name; most cover stages 2 to 4. People on dialysis or with a transplant have separate trials written for them.
Do I need a kidney biopsy to join?
Trials for IgA nephropathy, FSGS and lupus nephritis require a past biopsy confirming the diagnosis. Trials for diabetic or general chronic kidney disease do not.
Will I keep my current kidney and blood pressure medicines?
Yes. Kidney trials add the study treatment to a stable regimen, usually including an ACE inhibitor or ARB, and your own nephrologist continues to manage them.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Kidney Disease trials near you in Utah.

Get Matched — Free
No insurance required

Kidney disease trials evaluate SGLT2 inhibitors, dialysis protocols, renal transplant regimens, and supportive-care strategies for chronic and acute kidney disease.

All Kidney Disease trials →